Literature DB >> 12860258

Analysis of the apo(a) size polymorphism in Asian Indian populations: association with Lp(a) concentration and coronary heart disease.

F S Geethanjali1, Kalpana Luthra, Arno Lingenhel, A S Kanagasaba-Pathy, Jose Jacob, Lalit M Srivastava, Suman Vasisht, Hans-Georg Kraft, Gerd Utermann.   

Abstract

Most studies aiming to detect associations of genetic variation with common complex diseases, e.g. coronary heart disease (CHD) have been performed in populations with a western lifestyle but it is unclear whether associations detected in one geographic group exist also in others. We here have determined lipoprotein(a) levels and apo(a) K-IV-2 repeat genotypes in CHD patients (N=254) and controls (N=480) from two Asian Indian populations (Tamil Nadu and New Delhi). In both populations and also in the pooled dataset median Lp(a) levels were significantly elevated in the patients (27.4 mg/dl) compared with the controls (17.6 mg/dl). Apo(a) K-IV-2 allele frequencies were not different between the CHD patients and controls and thus did not explain the increased Lp(a) levels in CHD patients. Contrary to what has recently been observed in Black and White men short (K-IV<or=22) alleles associated with high Lp(a) concentration were not overrepresented in the patients. Rather, short (K-IV<or=22), intermediate (K-IV 23-29) and long (K-IV>or=30) apo(a) alleles were all associated with higher Lp(a) levels in the patients. Accordingly relative risk (estimated as odds ratio) for CHD rose continuously with increasing Lp(a) but was independent of apo(a) allele length. Together with previous studies our results indicate that the relation between apo(a) genotypes, Lp(a) levels, and CHD may be heterogeneous across ethnic groups and that it depends on the genetic architecture of the Lp(a) trait in a given population whether an association of K-IV-2 repeat length with CHD exists or not.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12860258     DOI: 10.1016/s0021-9150(03)00143-6

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  18 in total

Review 1.  Lipoprotein(a): an elusive cardiovascular risk factor.

Authors:  Lars Berglund; Rajasekhar Ramakrishnan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-09-02       Impact factor: 8.311

2.  Ethnicity and lipoprotein(a) polymorphism in Native Mexican populations.

Authors:  G Cardoso-Saldaña; A De La Peña-Díaz; J Zamora-González; R Gomez-Ortega; C Posadas-Romero; R Izaguirre-Avila; E Malvido-Miranda; M E Morales-Anduaga; E Anglés-Cano
Journal:  Ann Hum Biol       Date:  2006 Mar-Apr       Impact factor: 1.533

3.  Relook at lipoprotein (A): independent risk factor of coronary artery disease in north Indian population.

Authors:  Jamal Yusuf; Neeraj Yadav; Saibal Mukhopadhyay; Abhishek Goyal; Vimal Mehta; Vijay Trehan; Sanjay Tyagi
Journal:  Indian Heart J       Date:  2014-04-21

4.  Abnormal lipoprotein(a) levels predict coronary artery calcification in Southeast Asians but not in Caucasians: use of noninvasive imaging for evaluation of an emerging risk factor.

Authors:  Abhinav Sharma; Manoefris Kasim; Parag H Joshi; Zhen Qian; Eric Krivitsky; Kamran Akram; Sarah Rinehart; Gustavo Vazquez; Joseph Miller; Mohammad Saifur Rohman; Szilard Voros
Journal:  J Cardiovasc Transl Res       Date:  2011-04-12       Impact factor: 4.132

Review 5.  Structure, function, and genetics of lipoprotein (a).

Authors:  Konrad Schmidt; Asma Noureen; Florian Kronenberg; Gerd Utermann
Journal:  J Lipid Res       Date:  2016-04-13       Impact factor: 5.922

Review 6.  Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.

Authors:  Børge G Nordestgaard; Anne Langsted
Journal:  J Lipid Res       Date:  2016-09-27       Impact factor: 5.922

Review 7.  Lipoprotein(a): genotype-phenotype relationship and impact on atherogenic risk.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Wei Zhang; Tina Tran; Lars Berglund
Journal:  Metab Syndr Relat Disord       Date:  2011-07-12       Impact factor: 1.894

Review 8.  Looking at Lp(a) and Related Cardiovascular Risk: from Scientific Evidence and Clinical Practice.

Authors:  Thomas M Stulnig; Claudia Morozzi; Roman Reindl-Schwaighofer; Claudia Stefanutti
Journal:  Curr Atheroscler Rep       Date:  2019-07-27       Impact factor: 5.113

9.  Nonsynonymous SNPs in LPA homologous to plasminogen deficiency mutants represent novel null apo(a) alleles.

Authors:  Benjamin M Morgan; Aimee N Brown; Nikita Deo; Tom W R Harrop; George Taiaroa; Peter D Mace; Sigurd M Wilbanks; Tony R Merriman; Michael J A Williams; Sally P A McCormick
Journal:  J Lipid Res       Date:  2019-12-05       Impact factor: 5.922

10.  The apolipoprotein(a) gene: linkage disequilibria at three loci differs in African Americans and Caucasians.

Authors:  Jill Rubin; Han Jo Kim; Thomas A Pearson; Steve Holleran; Lars Berglund; Rajasekhar Ramakrishnan
Journal:  Atherosclerosis       Date:  2008-03-04       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.